Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F7VP7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,352
Award facts
- Contract value 100% obligated
- $30,351.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,351.56 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on February 4, 2026, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of February 5, 2026, represents a single transaction under a larger indefinite delivery contract vehicle. The award was made on a competitive, non-set-aside basis, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressive medication commonly used in military and federal healthcare systems for the treatment of rheumatoid arthritis and other autoimmune conditions.
This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As the prime pharmaceutical vendor under this comprehensive global contract, AmerisourceBergen supplies a broad range of specialty medications, brand-name and generic drugs, vaccines, medical devices, and related healthcare commodities to support military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions worldwide. The company's parent organization is Cencora, Inc., which operates through the AmerisourceBergen brand and maintains similar large-value pharmaceutical supply contracts with the Defense Logistics Agency and Department of Veterans Affairs.
Quick answers
Who was awarded contract SPE2DR26F7VP7?
SPE2DR26F7VP7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F7VP7 worth?
The government has obligated $30,352 on SPE2DR26F7VP7.
Is contract SPE2DR26F7VP7 an order under another contract?
Yes. SPE2DR26F7VP7 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VP7 competed?
The extent of competition for SPE2DR26F7VP7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award